Lutathera - Drug Insight, 2019 report provides comprehensive information of the drug, Lutathera. It includes drugs overview, Lutathera mechanism of action, clinical trials, regulatory milestones, deals & Lutathera's partnerships. It further provides Lutathera`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted Lutathera sales till 2021. The report also throws light on Lutathera market competition and emerging therapies in the same space as Lutathera. Lutathera SWOT analysis is also featured. * Depending on information availability.
Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by the research team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
Scope of the report
Reasons to Buy
Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by the research team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
Scope of the report
- A comprehensive Lutathera overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
- Lutathera Patent information in United States (US) and Europe (EU) has been highlighted
- Lutathera API manufacturers in United States, Europe, China and India
- The report contains historical and forecasted Lutathera sales till 2021
- Comprehensive coverage of the emerging therapies (Phase III) in the space where Lutathera operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
- The report also features the Lutathera SWOT analysis
Reasons to Buy
- Establish a comprehensive understanding of the drug, Lutathera
- Access to Lutathera API manufacturers details to devise API procurement strategy for generic development
- Plan developmental timelines around Lutathera patents for the major markets- US and EU
- Understand current and future Lutathera`s growth through its historical and forecasted sales
- Identify and understand the current in-market competitors for Lutathera
- Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
- Identify and plan ahead for prospective emerging players and their products operating in the same space as Lutathera
- Identify opportunities in the same area as with Lutathera SWOT analysis
Table of Contents
1. Report Introduction6. Lutathera Patent Details7. Lutathera Market Competition
2. Lutathera - Overview
3. Global API Manufacturers
4. Product Details
5. Lutathera Global Sales Assessment
8. Lutathera Emerging Therapies
9. Lutathera SWOT Analysis
List of Tables
List of Figures